RecruitingNot Applicable

Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

United States26 participantsStarted 2023-09-18

Plain-language summary

The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms. Exclusion Criteria: * Inability to provide informed consent. * Patients with previous gastroesophageal surgery or pneumatic dilation. * Esophageal botulinum toxin injection within the prior 12 months. * Esophageal stricture * Achalasia types I and II * Allergy to Lidocaine or other local anesthetics * Subjects on anticoagulation * Bilateral nasal obstruction * Pregnancy or breast feeding

What they're measuring

Number of subjects to have opioid-induced esophageal dysfunction resolution

Timeframe: 4 weeks

Trial details

NCT IDNCT05854303

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11

Contact for this trial

Mariah Robran

507-266-3595 robran.mariah@mayo.edu

View on ClinicalTrials.gov More Opioid-Induced Esophageal Dysfunction trials